Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
By Clifford R. Jack Jr., M. Shiung, Jeffrey L. Gunter, P. O'brien, S. Weigand, David S. Knopman, Brad Boeve, R. Ivnik, Glenn E. Smith, R. Cha and 2 more. Neurology, 2004
858 citations recorded by the source corpus.
Subfields: Cognitive Neuroscience, Physiology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/e4c189b2b1ef5d4e3b2633d2fbfa28e200fa6e70
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cognitive Neuroscience
- Randy L. Buckner
- Abraham Z. Snyder
- John C. Morris
- Mark A. Mintun
- Marcus E. Raichle
- Yvette I. Sheline
- Anthony F. Fotenos
- Benjamin J. Shannon
In Physiology
- Randy L. Buckner
- Clifford R. Jack Jr.
- John C. Morris
- Nick C Fox
- Ronald C. Petersen
- William E. Klunk
- A. Mitchell
- Brad Boeve
In Psychiatry and Mental health
- Randy L. Buckner
- John C. Morris
- Clifford R. Jack Jr.
- Abraham Z. Snyder
- Ronald C. Petersen
- Nick C Fox
- A. Mitchell
- John Q. Trojanowski
Citations in the corpus
- Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory (2005, background): “Structural atrophy predicts conversion from early to late stages of AD (Fox et al., 1999; Killiany et al., 2002; Jack et al., 2004).”
- Tensor-Based Morphometry as a Neuroimaging Biomarker for Alzheimer’s Disease: An MRI Study of 676 AD, MCI, and Normal Subjects (2008, neutral): “…conversion to AD over a specific follow-up interval (Jack et al., 1998; Scahill et al., 2003; Apostolova et al., 2006; Fleisher et al., 2008), and which measures link best with standard cognitive assessments (Fox et al., 1999; Jack et al., 2004; Thompson and Apostolova, 2007; Ridha et al., 2008).”
- Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI) (2005, neutral): “ntorhinal cortex and hippocampus in the stage of MCI, rogress to temporal and parietal lobes in AD, and finally nvolve the frontal lobes in late stages of AD [26,31,37-39].”
- MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers (2008, background): “…longitudinal MRI studies have shown increased rates of hippocampal volume loss in Alzheimer’s disease (Jack Jr et al., 2000, 2008b; Du et al., 2004; Jack et al., 2004; Fox et al., 2005; Hashimoto et al., 2005; van de Pol et al., 2005) and mild cognitive impairment (MCI, a transitional stage to…”
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease (2009, positive): “Quality control testing in our laboratory shows that the intra-class correlation coeffi-cient for test–retest reproducibility of ventricle rate measurements from short interval serial MRI scans with this method is 0.91 which is better than whole brain boundary shift integral (Jack et al ., 2004).”
- Head size, age and gender adjustment in MRI studies: a necessary nuisance? (2010, methodology): “Contents lists available at ScienceDirect NeuroImage j ourna l homepage: www.e lsev ie r.com/ locate /yn img Head size, age and gender adjustment in MRI studies: a necessary nuisance?”
- Automatic classification of MR scans in Alzheimer’s disease (2008, neutral): “This was ensured by excluding four AD subjects from group II when compared to their control group.”
- Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies (2009, methodology): “Eight studies (three using Mayo definition and five not using Mayo definition) examined the risk of dementia or AD in healthy age comparable controls head-to-head with the risk in individuals with MCI, a total pooled sample of 6713 individuals (39, 44, 56, 65, 67, 71, 73).”
- Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial (2010, neutral): “First, in studies over longer periods (up to 5 years) it has been found that the rate of whole brain atrophy in MCI is correlated with cognitive decline in several tests, including the MMSE [5].”